AIM ImmunoTech AIM
NYSE AIM
$0.17 -0.01 (-6.52%)
As of: Sep 29, 2026 · 3:59 PM EDT

AIM ImmunoTech (AIM) Operating Interest Expenses (2020 - 2021)

Updated

AIM ImmunoTech (AIM) recorded Operating Interest Expenses of -$48,000 in Q4 2021, compared with $10,000 a year earlier.

Analysis

AIM ImmunoTech (AIM) Operating Interest Expenses (2020 - 2021) Analysis & Trends

For FY2021, AIM ImmunoTech reported Operating Interest Expenses of $19,000, down 68.9% from FY2020.

  • Across earlier years, Operating Interest Expenses came in at $61,000 in FY2020 (-9.0%) and $67,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -48,000.00
Jun 30, 2021 53,000.00
Mar 31, 2021 14,000.00
Dec 31, 2020 10,000.00
Sep 30, 2020 20,000.00
Jun 30, 2020 15,000.00
Mar 31, 2020 16,000.00
API Access

AIM ImmunoTech Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=AIM&period=max&api_key=YOUR_API_KEY